130 related articles for article (PubMed ID: 12739139)
61. Noonan syndrome.
van der Burgt I
Orphanet J Rare Dis; 2007 Jan; 2():4. PubMed ID: 17222357
[TBL] [Abstract][Full Text] [Related]
62. Double-chambered right ventricle in an adult with Noonan syndrome.
Patel AM; Kim JB; Roberts AE; Aragam J
Cardiol Rev; 2006; 14(5):e16-20. PubMed ID: 16924159
[TBL] [Abstract][Full Text] [Related]
63. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
Lee ST; Ki CS; Lee HJ
Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
[TBL] [Abstract][Full Text] [Related]
64. Mild variable Noonan syndrome in a family with a novel PTPN11 mutation.
Zenker M; Voss E; Reis A
Eur J Med Genet; 2007; 50(1):43-7. PubMed ID: 17052965
[TBL] [Abstract][Full Text] [Related]
65. Additional evidence that PTPN11 mutations play only a minor role in the pathogenesis of non-syndromic atrioventricular canal defect.
Sarkozy A; Lepri F; Marino B; Pizzuti A; Digilio MC; Dallapiccola B
Am J Med Genet A; 2006 Sep; 140(18):1970-2. PubMed ID: 16892325
[No Abstract] [Full Text] [Related]
66. Little response to zoledronic acid in a child of juvenile myelomonocytic leukemia (JMML) harboring the PTPN11 mutation.
Shimada H; Shima H; Shimasaki N; Yoshihara H; Mori T; Takahashi T
Ann Oncol; 2005 Aug; 16(8):1400. PubMed ID: 15857842
[No Abstract] [Full Text] [Related]
67. Systemic lupus erythematosus and other autoimmune disorders in children with Noonan syndrome.
Lopez-Rangel E; Malleson PN; Lirenman DS; Roa B; Wiszniewska J; Lewis ME
Am J Med Genet A; 2005 Dec; 139(3):239-42. PubMed ID: 16283670
[No Abstract] [Full Text] [Related]
68. Germline KRAS mutations cause Noonan syndrome.
Schubbert S; Zenker M; Rowe SL; Böll S; Klein C; Bollag G; van der Burgt I; Musante L; Kalscheuer V; Wehner LE; Nguyen H; West B; Zhang KY; Sistermans E; Rauch A; Niemeyer CM; Shannon K; Kratz CP
Nat Genet; 2006 Mar; 38(3):331-6. PubMed ID: 16474405
[TBL] [Abstract][Full Text] [Related]
69. PTPN11 mutations and genotype-phenotype correlations in Noonan and LEOPARD syndromes.
Ogata T; Yoshida R
Pediatr Endocrinol Rev; 2005 Jun; 2(4):669-74. PubMed ID: 16208280
[TBL] [Abstract][Full Text] [Related]
70. Noonan syndrome mutation Q79R in Shp2 increases proliferation of valve primordia mesenchymal cells via extracellular signal-regulated kinase 1/2 signaling.
Krenz M; Yutzey KE; Robbins J
Circ Res; 2005 Oct; 97(8):813-20. PubMed ID: 16166557
[TBL] [Abstract][Full Text] [Related]
71. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
72. Early fetal death associated with compound heterozygosity for Noonan syndrome-causative PTPN11 mutations.
Becker K; Hughes H; Howard K; Armstrong M; Roberts D; Lazda EJ; Short JP; Shaw A; Patton MA; Tartaglia M
Am J Med Genet A; 2007 Jun; 143A(11):1249-52. PubMed ID: 17497712
[No Abstract] [Full Text] [Related]
73. The SH2 tyrosine phosphatase shp2 is required for mammalian limb development.
Saxton TM; Ciruna BG; Holmyard D; Kulkarni S; Harpal K; Rossant J; Pawson T
Nat Genet; 2000 Apr; 24(4):420-3. PubMed ID: 10742110
[TBL] [Abstract][Full Text] [Related]
74. Germ-line and somatic PTPN11 mutations in human disease.
Tartaglia M; Gelb BD
Eur J Med Genet; 2005; 48(2):81-96. PubMed ID: 16053901
[TBL] [Abstract][Full Text] [Related]
75. Genotype-phenotype correlation in congenital heart disease.
Lewin MB; Glass IA; Power P
Curr Opin Cardiol; 2004 May; 19(3):221-7. PubMed ID: 15096954
[TBL] [Abstract][Full Text] [Related]
76. Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome.
Sarkozy A; Conti E; Digilio MC; Marino B; Morini E; Pacileo G; Wilson M; Calabrò R; Pizzuti A; Dallapiccola B
J Med Genet; 2004 May; 41(5):e68. PubMed ID: 15121796
[No Abstract] [Full Text] [Related]
77. The PTPN11 gene is not implicated in nonsyndromic hypertrophic cardiomyopathy.
Roberts AE; Hult B; Rehm HL; Rehm HL; McDonough B; Barr S; Seidman CE; Seidman JG; Kucherlapati RS
Am J Med Genet A; 2005 Jan; 132A(3):333-4. PubMed ID: 15578621
[No Abstract] [Full Text] [Related]
78. Mammalian SH2-containing protein tyrosine phosphatases.
Adachi M; Fischer EH; Ihle J; Imai K; Jirik F; Neel B; Pawson T; Shen S; Thomas M; Ullrich A; Zhao Z
Cell; 1996 Apr; 85(1):15. PubMed ID: 8620532
[No Abstract] [Full Text] [Related]
79. Beta thalassemia major and Noonan syndrome - Two genetic disorders manifest in the blood film.
Tseu B; Siow W; Pushkaran B; Cheesebrough B; Bain BJ
Am J Hematol; 2020 Sep; 95(9):1113-1114. PubMed ID: 32112432
[No Abstract] [Full Text] [Related]
80. Hyperthrophic cardiomyopathy and the PTPN11 gene.
Sarkozy A; Conti E; Lepri FR; Pizzuti A; Dallapiccola B; Autore C; Tartaglia M
Am J Med Genet A; 2005 Jul; 136(1):93-4. PubMed ID: 15937948
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
